Future research will focus on determining whether targeting ALYREF can reverse platinum resistance and exploring the development of small-molecule inhibitors of ALYREF, with the goal of providing novel therapeutic strategies for drug-resistant ovarian cancer patients. The gene discussed is ALYREF; the disease is ovarian carcinoma.